Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents
Authors
Keywords
GluN2B-selective NMDAR antagonist, 3-n-Butylphthalide, PK study, Anti-stroke, Brain-penetrant
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 227, Issue -, Pages 113876
Publisher
Elsevier BV
Online
2021-10-09
DOI
10.1016/j.ejmech.2021.113876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis
- (2021) Zhaoxing Chu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- L-3-n-butylphthalide attenuates inflammation response and brain edema in rat intracerebral hemorrhage model
- (2020) Zhou Zeng et al. Aging-US
- A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
- (2020) Wenwu Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Excitotoxicity: Still Hammering the Ischemic Brain in 2020
- (2020) Dennis W. Choi Frontiers in Neuroscience
- Hypoxic preconditioning relieved ischemic cerebral injury by promoting immunomodulation and microglia polarization after middle cerebral artery occlusion in rats
- (2019) Lu Huang et al. BRAIN RESEARCH
- Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model
- (2019) Masahiro Fuwa et al. Scientific Reports
- Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1- b ]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents
- (2018) Linkui Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Global Burden of Stroke
- (2018) Mira Katan et al. SEMINARS IN NEUROLOGY
- N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression
- (2018) Ling-Er Huang et al. Scientific Reports
- Targeting NMDA receptors in stroke: new hope in neuroprotection
- (2018) Qiu Jing Wu et al. Molecular Brain
- Current advances in ischemic stroke research and therapies
- (2018) Derek Barthels et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Left-right asymmetry influenced the infarct volume and neurological dysfunction following focal middle cerebral artery occlusion in rats
- (2018) Zhiyong Zhai et al. Brain and Behavior
- Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins
- (2017) Ingo H. Greger et al. NEURON
- GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors
- (2017) Brice Mullier et al. NEUROPHARMACOLOGY
- MRI Guiding of the Middle Cerebral Artery Occlusion in Rats Aimed to Improve Stroke Modeling
- (2017) Ilya L. Gubskiy et al. Translational Stroke Research
- Reversible Disruption of Neuronal Mitochondria by Ischemic and Traumatic Injury Revealed by Quantitative Two-Photon Imaging in the Neocortex of Anesthetized Mice
- (2016) Mikhail Kislin et al. JOURNAL OF NEUROSCIENCE
- Mechanism of MenE Inhibition by Acyl-Adenylate Analogues and Discovery of Novel Antibacterial Agents
- (2015) Joe S. Matarlo et al. BIOCHEMISTRY
- Safety Surveillance of Traditional Chinese Medicine: Current and Future
- (2015) Shwu-Huey Liu et al. DRUG SAFETY
- Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects
- (2015) Hongjie Yuan et al. NEURON
- 3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia
- (2014) Hanqin Wang et al. Neural Regeneration Research
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Traditional Chinese Medicine-Based Network Pharmacology Could Lead to New Multicompound Drug Discovery
- (2012) Jian Li et al. Evidence-based Complementary and Alternative Medicine
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Synthesis and Biological Characterization of 3-Substituted 1H-Indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors. Part 2
- (2012) Rosaria Gitto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-ContainingN-Methyl-d-aspartate Receptors
- (2011) Rosaria Gitto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
- (2011) Erkan Karakas et al. NATURE
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
- (2008) Mathew J Reeves et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now